🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12475+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12475 recruiting trials

Phase 2RecruitingNCT06084897

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

👨‍⚕️ Wen-Yang Liu, MD, Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT07118137

Memory Deterioration in Alzheimer Disease

👨‍⚕️ Axel Sandvig Professor, MD PhD, Norwegian University of Science and Technology (NTNU)📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06349434

The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI

🏥 Kessler Foundation📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT05848310

Preoperative Serum FGF19 in the Prognosis of Biliary Atresia

🏥 Children's Hospital of Fudan University📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT05670288

Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury

👨‍⚕️ Jereme Wilroy, PhD, University of Alabama at Birmingham📍 1 site📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT06022029

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

🏥 OncoNano Medicine, Inc.📍 16 sites📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT05882058

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

🏥 Boehringer Ingelheim📍 59 sites📅 Started Oct 2023View details ↗
NARecruitingNCT06767592

A Study of Probiotics in IgA Nephropathy

🏥 University of Leicester📍 1 site📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT05804669

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

🏥 Crinetics Pharmaceuticals Inc.📍 1 site📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT05561387

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

👨‍⚕️ Sikander Ailawadhi, SWOG Cancer Research Network📍 397 sites📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT05833763

A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.

🏥 Australasian Leukaemia and Lymphoma Group📍 2 sites📅 Started Oct 2023View details ↗
Phase 2, PHASE3RecruitingNCT06026163

Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress

👨‍⚕️ Nehad Nasef, Neonatology Consultant📍 2 sites📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT06022861

A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

🏥 Shandong Boan Biotechnology Co., Ltd📍 1 site📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT06012240

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

👨‍⚕️ ABBVIE INC., AbbVie📍 267 sites📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT05922930

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

👨‍⚕️ Amir Jazaeri, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT05362929

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

👨‍⚕️ Kseniya Kobets, MD, Montefiore Medical Center📍 1 site📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT05959694

A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 25 sites📅 Started Oct 2023View details ↗
RecruitingNCT05932589

Neurophysiologic Biomarkers in Rett Syndrome

👨‍⚕️ Eric Marsh, MD, PhD, Children's Hospital of Philadelphia📍 6 sites📅 Started Oct 2023View details ↗
NAEnrolling by InvitationNCT06608407

Platelet Rich Plasma in the Prevention of Adhesion Reformation

🏥 Fu Xing Hospital, Capital Medical University📍 2 sites📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT05583721

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

👨‍⚕️ Parul Rai, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Oct 2023View details ↗
← PreviousPage 370 of 624Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →